From innovation to patient impact →

Growth through
innovation.

A fully integrated pharmaceutical and cosmeceutical company, developing and manufacturing products across Romania and India, with a presence in more than 30 countries worldwide.

Realistic multi dose pen and sterile glass vial

Sterile · Fill finish

GLP-1 Oncology

A global reach

Presence across 30+ countries through focused local partnerships.

A robust pipeline

20+ products in various stages of development.

Quality led execution

14 dossiers approved,
30 filed globally

Dedicated R&D

Sterile injectable development from formulation and prototypes to technology transfer readiness.

Positioning

Bridging innovation to market access.

An international pharmaceutical and cosmeceutical company focused on portfolio development, scale up, manufacturing and robust supply across selected advanced international markets, with commercial accountability, not intermediation.

Portfolio Strategy & Product Development

Building a focused portfolio through selective acquisition, in licensing and purposeful product development aligned with long term market opportunity.

Commercialisation & Market Access

Taking products from scale up and manufacturing to market through direct commercial execution and trusted local partnerships.

Lifecycle Growth & Market Expansion

Growing long term product value through active lifecycle management, wider geographic reach and sustained investment in brand equity and market share.

To be a trusted partner whose quality products and reliable manufacturing translate into meaningful, sustainable market presence across diverse geographies.

Pharma Verticals

5 Product families.

Full molecule level detail sits in the catalogue. Here is how the portfolio is structured.

Oncology

40 Products

Cytotoxic and targeted therapy injectables, lyophilised and solution presentations, manufactured in dedicated contained suites.

General Injectables

34 Products

Anti-infectives, anaesthesia, critical care and hospital injectables across vials, ampoules, prefilled syringes and multi dose pens.

Oral Solids

25 Products

Tablets and capsules, including high potency and modified release formats, produced to OEB4 containment standards.

Biosimilars & Peptides

13 Products

Monoclonal antibodies and peptide therapeutics, supplied in cold chain controlled injectable presentations.

Specialty Products

8 Products

Contrast media, anaesthesia gases and specialist products for hospitals and healthcare institutions.

View / download full catalogue ↗

Capabilities

What we build, make and partner on.

Research & Development

Dedicated R&D, built around sterile injectables

A dedicated R&D centre focused on sterile injectables, from early formulation and proof of concept through scale up and readiness for technology transfer.

Proof of concept prototypes

Development of stable formulations

Analytical method development

Scale up and technology transfer readiness

Formulation → Tech transfer

EU-GMP · WHO-GMP

Manufacturing

Sterile & oral solid capacity, two hubs

Sterile fill finish and lyophilization alongside high potency oral solids, across EU-GMP and WHO-GMP certified suites in Romania and India.

Sterile fill finish and lyophilization

High potency oral solids

EU-GMP and WHO-GMP suites

Serialization ready packaging

Robust Supply Chain

Reliable supply across selected advanced international markets

Flexible commercial models, licensing collaborations, contract manufacturing, and territory exclusive distribution.

Licensing collaborations

CDMO/CMO

Territory exclusive distribution

License · Make · Distribute

Quality & compliance

The record a buyer can audit.

Every suite operates to internationally recognised standards, with documentation available to qualified partners under Non Disclosure Agreement (NDA).